RDC 954/2024: Updates to the Simplified Drug Registration Procedure

Experts discuss RDC 954/2024 and its impact on drug registration in Brazil.

Key Changes and Impacts for Drug Manufacturers The recent update of RDC 954/2024 brought significant changes to the simplified procedure for registering medicines in Brazil. In an exclusive event held by ANVISA on March 13, experts discussed the main guidelines and their impacts on the pharmaceutical sector. QR Group has closely followed the news to […]